Reproductive Lesions in Female Harlan Sprague-Dawley Rats Following Two-Year Oral Treatment with Dioxin and Dioxin-like Compounds
| Autor: | Abraham Nyska, Grace E. Kissling, Micheal P. Jokinen, Katsuhiko Yoshizawa, Denis P. Orzech, Donald M. Sells, Nigel J. Walker, Michael E. Wyde, Amy E. Brix |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
medicine.medical_specialty
Polychlorinated Dibenzodioxins Uterus Administration Oral Ovary Biology Dioxins Toxicology Pathology and Forensic Medicine Rats Sprague-Dawley Oral administration Internal medicine Toxicity Tests medicine Animals Endocrine system Molecular Biology Chronic toxicity Benzofurans Metaplasia Reproduction Cell Biology Polychlorinated Biphenyls Rats medicine.anatomical_structure Endocrinology Epidermoid carcinoma In utero Endometrial Hyperplasia Uterine Neoplasms Toxicity Carcinogens Carcinoma Squamous Cell Female |
| Zdroj: | Toxicologic Pathology. 37:921-937 |
| ISSN: | 1533-1601 0192-6233 |
| DOI: | 10.1177/0192623309351721 |
| Popis: | Results from previously published animal studies suggest that prenatal and postnatal exposure to dioxin and dioxin-like compounds (DLCs) may profoundly affect the reproductive system of both sexes via endocrine disruption. In the present work, we evaluate the toxicity and carcinogenicity of various DLCs, with an emphasis on their effect on the reproductive organs, induced by chronic exposure of female adult Harlan Sprague-Dawley rats. This investigation represents part of an initiative of the National Toxicology Program to determine the relative potency of chronic toxicity and carcinogenicity of polychlorinated dioxins, furans, and biphenyls. For fourteen, thirty-one, or fifty-three weeks or for two years, animals were administered by gavage 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD); 3,3′,4,4′,5-pentachlorobiphenyl (PCB126); 2,3,4,7,8-pentachlorodibenzofuran (PeCDF); 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153); 2,3′,4,4′,5-pentachlorobiphenyl (PCB118); a tertiary mixture of TCDD, PCB126, and PeCDF; a binary mixture of PCB126 and 153; or a binary mixture of PCB126 and PCB118. The ranges of treatment-related changes in the reproductive system included chronic active inflammation in the ovary that occurred in the 1,000 and 3,000 μg/kg core groups (two-year exposure) of PCB153 and in the 300 ng/3,000 μg/kg core group of binary mixture of PCB126 and PCB153. Increases in the incidence of acute and/or chronic active inflammation of the uterus were observed in all dosed groups, including the stop-exposure group (withdrawal after thirty-week exposure) of PeCDF and the 1,000 μg/kg and/or higher group dosed with PCB153. The incidence of cystic endometrial hyperplasia was marginally increased in the 92 PeCDF ng/kg group at two years. The incidence of squamous metaplasia was significantly increased in the 44 ng/kg and higher dose group, including the stop-exposure group. The incidence of uterine squamous cell carcinoma was significantly or marginally increased in the 6 ng/kg core and 100 ng/kg stop-exposure groups of TCDD and in the 300 ng/300 μg/kg core group that received the binary mixture of PCB126 and 153. The incidence of uterine carcinoma was marginally increased in the 92 ng/kg PeCDF group at two years and clearly increased in the 1,000 and 4,600 μg/kg PCB118 core group and the 4,600 μg/kg stop group. In the studies of PCB 126, the tertiary mixture, and the binary mixture of PCB126 and PCB118, no increased incidence of any change occurred in the reproductive systems. The range of changes seen with the different compounds suggests that more than one mechanism may have been involved in promoting the female reproductive pathology. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|